KalVista Pharmaceuticals Inc (KALV)
9.33
+0.37
(+4.13%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Net Income (Quarterly): -40.44M for July 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | -40.44M |
| April 30, 2024 | -44.65M |
| January 31, 2024 | -29.03M |
| October 31, 2023 | -27.65M |
| July 31, 2023 | -25.32M |
| April 30, 2023 | -26.30M |
| January 31, 2023 | -21.30M |
| October 31, 2022 | -22.26M |
| July 31, 2022 | -23.04M |
| April 30, 2022 | -24.11M |
| January 31, 2022 | -22.47M |
| October 31, 2021 | -19.65M |
| July 31, 2021 | -16.11M |
| April 30, 2021 | -14.96M |
| January 31, 2021 | -10.05M |
| October 31, 2020 | -10.43M |
| July 31, 2020 | -10.81M |
| April 30, 2020 | -6.584M |
| January 31, 2020 | -9.291M |
| October 31, 2019 | -5.903M |
| July 31, 2019 | -7.338M |
| April 30, 2019 | -8.526M |
| Date | Value |
|---|---|
| January 31, 2019 | -3.956M |
| October 31, 2018 | -3.304M |
| July 31, 2018 | -5.03M |
| April 30, 2018 | -0.657M |
| January 31, 2018 | -5.234M |
| October 31, 2017 | -4.986M |
| July 31, 2017 | -4.928M |
| April 30, 2017 | -4.202M |
| January 31, 2017 | -7.644M |
| September 30, 2016 | -2.385M |
| June 30, 2016 | -7.35M |
| March 31, 2016 | -6.607M |
| December 31, 2015 | -5.659M |
| September 30, 2015 | -4.991M |
| June 30, 2015 | -9.012M |
| March 31, 2015 | -5.184M |
| December 31, 2014 | -4.714M |
| September 30, 2014 | -3.995M |
| June 30, 2014 | -2.635M |
| March 31, 2014 | -2.015M |
| December 31, 2013 | -1.207M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-44.65M
Minimum
Apr 2024
-6.584M
Maximum
Apr 2020
-21.29M
Average
-22.26M
Median
Oct 2022
Net Income (Quarterly) Benchmarks
| Nuwellis Inc | 2.358M |
| Perspective Therapeutics Inc | -15.12M |
| Electromed Inc | 1.474M |
| Xtant Medical Holdings Inc | -5.024M |
| Myomo Inc | -0.9664M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 44.22M |
| EPS Diluted (Quarterly) | -0.87 |
| Enterprise Value | 266.70M |
| Earnings Yield | -38.37% |
| Normalized Earnings Yield | -17.35 |